A propos

PU-PH Pharmacologie


CHU de Poitiers
Service de Pharmacologie clinique et Vigilances
2, rue de la Milétrie, BP 577
86021 Poitiers Cedex

Tél : 05 49 44 44 53 Fax : 05 49 44 38 45

Laboratoire de Neurosciences Expérimentales et Cliniques (équipe 3)
Bât. B36
Pôle Biologie Santé
1, rue Georges Bonnet
BP 633
86022 Poitiers Cedex

e-mail : m.c.perault-pochat@chu-poitiers.fr


Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S. Time course of MPTP toxicity on translational control protein expression in mice brain. Toxicol Lett. 2010, 196(1):51-5.

Chavant F, Deguil J, Pain S, Ingrand I, Milin S, Fauconneau B, Perault MC, Lafay-Chebassier C. Imipramine, in part through TNF-alpha inhibition, prevents cognitive decline and Abeta accumulation in a mouse model of Alzheimer’s disease. J Pharmacol Exp Ther. 2010, 332(2):505-14.

Deguil J, Chavant F, Lafay-Chebassier C, Pérault-Pochat MC, Fauconneau B, Pain S. Neuroprotective Effect of PACAP on Translational Control Alteration and Cognitive Decline in MPTP Parkinsonian Mice. Neurotox Res. 2010, 17(2):142-55.

Chavant F, Lafay-Chebassier C, Beauchant M, Pérault-Pochat MC. Hépatite à la doxycycline : à propos d’un cas. Gastroenterol Clin Biol. 2008 (French).

Deguil J, Pérault-Pochat MC, Chavant F, Lafay-Chebassier C, Fauconneau B, Pain S. Activation of the protein p70S6K via ERK phosphorylation by cholinergic muscarinic receptors stimulation in human neuroblastoma cells and in mice brain. Toxicol. Lett. 2008, 182(1-3):91-6.

Favrelière S, Lafay-Chebassier C, Alkhidir F, Merlet I, Pérault Pochat MC. [Drug-induced dementia : a case/non-case study in the French pharmacovigilance database.] Therapie. 2007, 62(6):507-11. French.

Lafay-Chebassier C, Pérault-Pochat MC, Page G, Rioux Bilan A, Damjanac M, Pain S, Houeto JL, Gil R, Hugon J. The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. J Neurosci Res. 2006, 84(6):1323-34.

Paccalin M, Al Khidir F, Barc SP, Pluchon C, Perault-Pochat MC, Gil R, Hugon J. Peripheral p70S6k levels and emotional memory in patients with Alzheimer’s disease. Neurosci Lett. 2006, 410(3):162-4.

Krupka E, Venisse N, Lafay C, Gendre D, Diquet B, Bouquet S, Perault MC. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers. Eur J Clin Pharmacol. 2006, 62(8):653-9.

Page G, Rioux Bilan A, Ingrand S, Lafay-Chebassier C, Pain S, Perault Pochat MC, Bouras C, Bayer T, Hugon J. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer’s disease. Neuroscience. 2006, 139(4):1343-54.

Pichon A, Venisse N, Krupka E, Pérault-Pochat MC, Denjean A. Urinary and blood concentrations of beta2-agonists in trained subjects : comparison between routes of use. Int J Sports Med. 2006, 27(3):187-92.

Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer’s disease. J Neurochem. 2005, 94(1):215-25.

Krupka E, Gendre D, Lafay C, Le Dez O, Gelineau P, Perault-Pochat MC. [Perception of written and oral information by 50 healthy volunteers from a monocentric study.] Therapie. 2005, 60(1):31-8. French.

Flattet C, Remblier C, Pérault-Pochat MC. [Patient influence in drug imputability : a report of 17 cases.] Therapie. 2004, 59(6):645-9. French.

Cordonnier-Jourdin C, Saulnier JP, Favreliere S, Papet Y, Oriot D, Perault MC. [Poor agreement between clinical signs and concentration of digoxin in a premature child.] Therapie. 2003, 58(2):165-6. French.

Favreliere S, Perault MC, Huguet F, De Javel D, Bertrand N, Piriou A, Durand G. DHA-enriched phospholipid diets modulate age-related alterations in rat hippocampus. Neurobiol Aging. 2003, 24(2):233-43.

Lardeur JY, Remblier C, Viel S, Raud-Raynier P, Sosner P, Walter M, Baudier D, Perault-Pochat MC. [Myocardial infarct with protease inhibitors : a case report.] Therapie. 2002, 57(3):311-3. French.

Roy-Peaud F, Perault-Pochat MC, Paccalin M, Le Moal G, Landron C, Juhel L, Roblot P, Becq-Giraudon B. [Pigmented lesions secondary to indapamide] Rev Med Interne. 2002, 23(7):674. French.

Cracowski JL, Perault-Pochat MC, Stanke-Labesque F, Vandel B, Bessard G. Using a WWW-based module for problem-based learning in a cardiovascular pharmacology course. Acad Med. 2001, 76(4):394. Erratum in : Acad Med 2001, 76(7):692.

Goubault C, Perault MC, Leleu E, Bouquet S, Legros P, Vandel B, Denjean A. Effects of inhaled salbutamol in exercising non-asthmatic athletes. Thorax. 2001, 56(9):675-9.

Haas M, Perault MC, Bonnefoy P, Rodeau F, Caron F. [Interstitial pneumopathy due to flecainide.] Presse Med. 2001 Jun, 30(21):1062. French.

Remblier C, Kassir A, Richard D, Perault MC, Guibert S. [Parkinson syndrome from diltiazem] Therapie. 2001, 56(1):57-9. French.

Nicol B, Champagne X, Breux JP, Pasdeloup T, Remblier C, Perault MC, Vandel B. [Attitude of the clinican toward adverse effects of protease inhibitors] Therapie. 2000, 55(5):643-7. French.

Perault MC, Favreliere S, Minet P, Remblier C. [Benzodiazepines and pregnancy] Therapie. 2000, 55(5):587-95. Review. French.

Vandel S, Netillard C, Perault MC, Bel AM. Plasma levels of clozapine and desmethylclozapine are unaffected by concomitant ingestion of grapefruit juice. Eur J Clin Pharmacol. 2000, 56(4):347-8.

Sinnaeve O, Berthier M, Guillard O, Perault MC, Oriot D. [Chronic lead poisoning in children today. A pathology of poverty and social exclusion] Arch Pediatr. 1999, 6(7):762-7. Review. French.

Perault MC, Pinelli AL, Chauveau I, Scepi M, Remblier C, Vandel B. [Prospective study on admissions for iatrogenic adverse effects in the emergency service of hospital university center in Poitiers.] Therapie. 1999, 54(1):183-5. French.

  • L'actu du LNEC continue sur les réseaux sociaux !